Unipath ClearPlan Easy Fertility Monitor To Launch In First Quarter 1999
• By The Tan Sheet
Unipath Diagnostics will introduce its ClearPlan Easy OTC electronic fertility monitor in the first quarter of 1999 following 510(k) clearance by FDA on Oct. 30. The U.S., where about 3.5 million women become pregnant each year, will be the product's first market. Packaged with 20 disposable urine test sticks, the device will have a suggested retail price of $200. A pack of 30 additional test sticks will cost about $50.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
The UK’s research-based pharma industry and medical research charities have set out clear action points to drive greater diversity and inclusion in clinical trials.
Blenrep, GSK’s multiple myeloma therapy, faced a major setback when it was withdrawn from the market in 2022. The drug has since made a return as a second-line therapy, and is on track to being reimbursed in England.